Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/25/2025

Severe Clostridioides difficile Infection Presenting with Ileus

Diagnosis Without Diarrhea

  • The ESCMID guideline recognizes ileus—characterized by vomiting, absence of stool, and radiologic bowel distension—as a valid clinical presentation of CDI【1】.
  • Up to 30 % of surgical patients with CDI may initially lack diarrhea due to colonic dysmotility, and the absence of diarrhea can herald progression to fulminant infection【4】.

Severity Assessment

Clinical and Laboratory Markers

  • Leukocytosis > 15 × 10⁹ L⁻¹ is a validated severity marker and predicts poor outcomes【1】【4】.
  • Fever ≥ 38.5 °C is listed as an indicator of severe disease【1】【3】.
  • Abdominal pain together with signs of ileus (vomiting, absent stool) fulfills severity criteria【1】【2】.
  • Recent exposure to broad‑spectrum antibiotics is the primary risk factor for severe CDI【1】【4】.

Imaging Markers

  • Colonic wall thickening on CT is an imaging marker of severe CDI【1】【5】.
  • CT findings of wall thickening > 4 mm, pericolonic stranding, and unexplained ascites have ≈ 93 % specificity for CDI, though sensitivity ranges 52–70 %【5】.

Laboratory Testing

  • Stool toxin enzyme immunoassay (EIA) has a sensitivity of ≈ 60–90 % and should be performed even in the absence of diarrhea【6】.
  • Nucleic‑acid amplification testing (NAAT) offers higher sensitivity (≈ 80–100 %) when available【5】.
  • High‑risk patients should receive empiric therapy without awaiting test results【4】.

Endoscopic Evaluation

  • Full colonoscopy is contraindicated in severe or fulminant colitis because of perforation risk; flexible sigmoidoscopy may be considered only if stool tests are negative despite strong clinical suspicion【8】.

Immediate Therapeutic Strategy

Multi‑Route Antimicrobial Regimen (Ileus)

  • Oral/NG vancomycin 125 mg q6h (or via nasogastric tube)【1】.
  • IV metronidazole 500 mg q8h—necessary because IV metronidazole alone achieves poor colonic concentrations when ileus is present【1】.
  • Rectal vancomycin 500 mg in 100–500 mL saline retention enema q6h to ensure direct colonic delivery【1】.

Antibiotic Stewardship

  • Discontinue all non‑essential antibiotics immediately; if required for another infection, narrow the spectrum as much as possible【1】.

Medications to Avoid

  • Antiperistaltic agents (e.g., loperamide, diphenoxylate) should not be used【1】.
  • Opioid analgesics should be minimized because they can precipitate toxic megacolon【1】.

Surgical Consultation

  • Urgent surgical consultation is indicated for any of the following: ileus, severe systemic inflammation with leukocytosis, colonic distension on imaging, or elevated serum lactate【1】【4】.
  • Early subtotal colectomy with end ileostomy is the preferred operation if medical therapy fails【1】.

Supportive Care

  • Correct electrolyte abnormalities, especially potassium and magnesium【4】.
  • Maintain hemodynamic stability with intravenous fluid resuscitation【2】.

Monitoring and Escalation

  • Reassess clinical status after 3 days of therapy: look for reduced fever, abdominal pain, distension, and a declining white‑blood‑cell count【1】【2】.
  • Repeat imaging if the patient’s condition remains unclear【1】.
  • If no improvement or worsening occurs within 3–5 days, proceed urgently to colectomy【1】.
  • Metronidazole may require 3–5 days to show a response; however, surgery should not be delayed if the patient deteriorates【1】【2】.

All statements are derived from guideline‑based sources (ESCMID, IDSA, WSES) and peer‑reviewed literature, providing strong, evidence‑based recommendations for the management of severe CDI presenting with ileus.